Ignite Creation Date:
2024-05-19 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06414681
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-16
First Post:
2024-02-23
Brief Title:
Combination of Tagraxofusp With Pacritinib in Patients With Intermediate-1 or Higher Myelofibrosis Who Have Had Prior Therapy With the Approved JAK Inhibitors or in Which Therapy With the Approved JAK Inhibitors is Not Appropriate Contraindicated or Declined
Sponsor:
University of Kansas Medical Center
Organization:
University of Kansas Medical Center
Organization Data
Organization:
University of Kansas Medical Center
Class:
OTHER
Study ID:
STUDY00160238
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Kansas Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
Abdulraheem Yacoub
Responsible Party Title:
Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University of Kansas Medical Center
Old Name:
None
Old Organization:
None